Moderna pulls licensing submission for combo flu-COVID vaccine

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal influenza–COVID-19 mRNA vaccine candidate, mRNA-1083, so that it can submit efficacy data. The news comes a day after the US Food and Drug Administration announced that seasonal…
|
||||
You Might Like |